Judge Balks At ViroPharma's Bid To Halt Vancocin Generics
ViroPharma Inc.'s bid to halt the U.S. Food and Drug Administration's recent approval of three generic versions of its gastrointestinal antibiotic Vancocin hit a possible snag Thursday when a Washington federal...To view the full article, register now.
Already a subscriber? Click here to view full article